Crowther, Michael D., Dolton, Garry, Legut, Mateusz, Caillaud, Marine E., Lloyd, Angharad, Attaf, Meriem, Galloway, Sarah A. E., Rius, Cristina, Farrell, Colin P., Szomolay, Barbara ORCID: https://orcid.org/0000-0002-5375-5533, Ager, Ann ORCID: https://orcid.org/0000-0002-5763-8908, Parker, Alan L. ORCID: https://orcid.org/0000-0002-9302-1761, Fuller, Anna, Donia, Marco, McCluskey, James, Rossjohn, Jamie ORCID: https://orcid.org/0000-0002-2020-7522, Svane, Inge Marie, Phillips, John D. and Sewell, Andrew K. ORCID: https://orcid.org/0000-0003-3194-3135
2020.
Genome-wide CRISPR-Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1.
Nature Immunology
21
, 178 - 185.
10.1038/s41590-019-0578-8
|
|
|
Madura, Florian, Rizkallah, Pierre J. ORCID: https://orcid.org/0000-0002-9290-0369, Legut, Mateusz, Holland, Christopher J., Fuller, Anna, Bulek, Anna, Schauenburg, Andrea J., Trimby, Andrew, Hopkins, Jade R., Wells, Stephen A., Godkin, Andrew ORCID: https://orcid.org/0000-0002-1910-7567, Miles, John J., Sami, Malkit, Li, Yi, Liddy, Nathaniel, Jakobsen, Bent K., Loveridge, E. Joel, Cole, David K. ORCID: https://orcid.org/0000-0003-0028-9396 and Sewell, Andrew K. ORCID: https://orcid.org/0000-0003-3194-3135
2019.
TCR-induced alteration of primary MHC peptide anchor residue.
European Journal of Immunology
49
(7)
, pp. 1052-1066.
10.1002/eji.201948085
|
|
|
Sewell, Andrew K. ORCID: https://orcid.org/0000-0003-3194-3135 and Legut, Mateusz
2018.
Designer T-cells and T-cell receptors for customised cancer immunotherapies.
Current Opinion in Pharmacology
41
, pp. 96-103.
10.1016/j.coph.2018.05.005
|
|
|
Zhao, Xiang, Sankaran, Shvetha, Yap, Jiawei, Too, Chien Tei, Ho, Zi Zong, Dolton, Garry, Legut, Mateusz, Ren, Ee Chee, Sewell, Andrew K. ORCID: https://orcid.org/0000-0003-3194-3135, Bertoletti, Antonio, MacAry, Paul A., Brzostek, Joanna and Gascoigne, Nicholas R. J.
2018.
Nonstimulatory peptide?MHC enhances human T-cell antigen-specific responses by amplifying proximal TCR signaling.
Nature Communications
9
, 2716.
10.1038/s41467-018-05288-0
|
|
|
Legut, Mateusz, Dolton, Garry, Mian, Afsar, Ottmann, Oliver ORCID: https://orcid.org/0000-0001-9559-1330 and Sewell, Andrew ORCID: https://orcid.org/0000-0003-3194-3135
2018.
CRISPR-mediated TCR replacement generates superior anticancer transgenic T-cells.
Blood
131
(3)
, pp. 311-322.
10.1182/blood-2017-05-787598
|
|
|
Maciocia, Paul M., Wawrzyniecka, Patrycja A., Philip, Brian, Ricciardelli, Ida, Akarca, Ayse U., Onuoha, Shimobi C., Legut, Mateusz, Cole, David K. ORCID: https://orcid.org/0000-0003-0028-9396, Sewell, Andrew K. ORCID: https://orcid.org/0000-0003-3194-3135, Gritti, Giuseppe, Somja, Joan, Piris, Miguel A., Peggs, Karl S., Linch, David C., Marafioti, Teresa and Pule, Martin A.
2017.
Targeting the T cell receptor β-chain constant region for immunotherapy of T cell malignancies.
Nature Medicine
23
, pp. 1416-1423.
10.1038/nm.4444
|
|
|
Cole, David K. ORCID: https://orcid.org/0000-0003-0028-9396, Fuller, Anna, Dolton, Garry, Zervoudi, Efthalia, Legut, Mateusz, Miles, Kim, Blanchfield, Lori, Madura, Florian, Holland, Christopher J., Bulek, Anna M., Bridgeman, John S., Miles, John J., Schauenburg, Andrea J. A., Beck, Konrad ORCID: https://orcid.org/0000-0001-5098-9484, Evavold, Brian D., Rizkallah, Pierre J. ORCID: https://orcid.org/0000-0002-9290-0369 and Sewell, Andrew K. ORCID: https://orcid.org/0000-0003-3194-3135
2017.
Dual molecular mechanisms govern escape at immunodominant HLA A2-restricted HIV epitope.
Frontiers in Immunology
8
, 1503.
10.3389/fimmu.2017.01503
|
|
|
Donia, Marco, Kjeldsen, Julie Westerlin, Andersen, Rikke, Wulff Westergaard, Marie Christine, Bianchi, Valentina, Legut, Mateusz, Attaf, Meriem, Szomolay, Barbara ORCID: https://orcid.org/0000-0002-5375-5533, Ott, Sascha, Dolton, Garry, Lyngaa, Rikke, Hadrup, Sine Reker, Sewell, Andrew K. ORCID: https://orcid.org/0000-0003-3194-3135 and Svane, Inge Marie
2017.
PD-1+ polyfunctional T cells dominate the periphery after tumour-infiltrating lymphocyte therapy for cancer.
Clinical Cancer Research
23
(19)
, pp. 5779-5788.
10.1158/1078-0432.CCR-16-1692
|
|
|
|
Legut, Mateusz
2017.
Genome editing approaches for development of pan-population immunotherapies.
PhD Thesis,
Cardiff University.
Item availability restricted. |
|
|
Attaf, Meriem, Legut, Mateusz, Cole, David ORCID: https://orcid.org/0000-0003-0028-9396 and Sewell, Andrew K. ORCID: https://orcid.org/0000-0003-3194-3135
2015.
The T cell antigen receptor: the Swiss army knife of the immune.
Clinical and Experimental Immunology
181
(1)
, pp. 1-18.
10.1111/cei.12622
|
|
|
Uusi-Kerttula, Hanni, Legut, Mateusz, Davies, James Anthony ORCID: https://orcid.org/0000-0003-3569-4500, Jones, Rachel, Hudson, Emma, Hanna, Louise, Stanton, Richard James ORCID: https://orcid.org/0000-0002-6799-1182, Chester, John D. ORCID: https://orcid.org/0000-0002-7830-3840 and Parker, Alan L. ORCID: https://orcid.org/0000-0002-9302-1761
2015.
Incorporation of peptides targeting EGFR and FGFR1 into
the adenoviral fibre knob domain, and their evaluation as
targeted cancer therapies.
Human Gene Therapy
26
(5)
, pp. 320-329.
10.1089/hum.2015.015
|
|
|
Legut, Mateusz, Cole, David ORCID: https://orcid.org/0000-0003-0028-9396 and Sewell, Andrew K. ORCID: https://orcid.org/0000-0003-3194-3135
2015.
The promise of γδ T cells and the γδ T cell receptor for cancer immunotherapy.
Cellular and Molecular Immunology
12
, pp. 656-668.
10.1038/cmi.2015.28
|
|
|



Up a level